GB8332644D0 - Affinity purification of antigens - Google Patents

Affinity purification of antigens

Info

Publication number
GB8332644D0
GB8332644D0 GB838332644A GB8332644A GB8332644D0 GB 8332644 D0 GB8332644 D0 GB 8332644D0 GB 838332644 A GB838332644 A GB 838332644A GB 8332644 A GB8332644 A GB 8332644A GB 8332644 D0 GB8332644 D0 GB 8332644D0
Authority
GB
United Kingdom
Prior art keywords
antigens
affinity purification
affinity
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB838332644A
Other versions
GB2128630A (en
GB2128630B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of GB8332644D0 publication Critical patent/GB8332644D0/en
Publication of GB2128630A publication Critical patent/GB2128630A/en
Application granted granted Critical
Publication of GB2128630B publication Critical patent/GB2128630B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB08332644A 1982-04-12 1983-04-12 Method of affinity purification employing monoclonal antibodies Expired GB2128630B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36778182A 1982-04-12 1982-04-12
PCT/US1983/000524 WO1983003678A1 (en) 1982-04-12 1983-04-12 Method of affinity purification employing monoclonal antibodies

Publications (3)

Publication Number Publication Date
GB8332644D0 true GB8332644D0 (en) 1984-01-11
GB2128630A GB2128630A (en) 1984-05-02
GB2128630B GB2128630B (en) 1986-08-28

Family

ID=23448565

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08332644A Expired GB2128630B (en) 1982-04-12 1983-04-12 Method of affinity purification employing monoclonal antibodies

Country Status (11)

Country Link
EP (1) EP0105359A4 (en)
AT (1) AT393386B (en)
AU (1) AU622099B2 (en)
CA (1) CA1209907A (en)
CH (1) CH672028A5 (en)
DK (1) DK192191A (en)
ES (3) ES8404858A1 (en)
FI (1) FI88403C (en)
GB (1) GB2128630B (en)
IT (1) IT1219779B (en)
WO (1) WO1983003678A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4859611A (en) * 1985-02-28 1989-08-22 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) * 1987-03-23 1992-12-29 Amgen Inc. Methods for purification of platelet-derived growth factor
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
SE468653B (en) * 1987-03-06 1993-02-22 Perstorp Biolytica ADSORBENT FOR ISOCRATIC AFFINITY CHROMATOGRAPHY
JPS6463599A (en) * 1987-05-01 1989-03-09 Xoma Corp Purification of immunoglobulin by selective anti-idiotype bond
EP0371049B1 (en) * 1987-07-14 1992-06-03 The Victoria University Of Manchester Method for the diagnosis of infections with detection of lipopolysaccharide antigens
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5582862A (en) 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
JP2001502895A (en) * 1996-09-20 2001-03-06 ザ・ジェネラル・ホスピタル・コーポレイション Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
DK2708559T3 (en) * 2008-04-11 2018-06-14 Chugai Pharmaceutical Co Ltd Antigen-binding molecule capable of repeatedly binding two or more antigen molecules
CN108715614A (en) 2010-11-30 2018-10-30 中外制药株式会社 The antigen binding molecules combined are repeated with polymolecular antigen
BR112013021526B1 (en) 2011-02-25 2021-09-21 Chugai Seiyaku Kabushiki Kaisha VARIANT POLYPEPTIDE, METHODS FOR MAINTAINING OR DECREASE BINDING ACTIVITIES TO FCGRIIA (TYPE R) AND FCGRIIA (TYPE H) AND INCREASING FCGRIIB BINDING ACTIVITY OF A POLYPEPTIDE AND FOR SUPPRESSING THE PRODUCTION OF AN ANTIBODY AGAINST A POLYENDENDOPEPTIDE ANTIBODY FC, METHODS FOR THE PRODUCTION OF SUCH POLYPEPTIDE WITH MAINTAINED OR DECREASED AND INCREASED BINDING ACTIVITIES AND FOR THE SUPPRESSED PRODUCTION OF AN ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE OF A POLYPEPTIDE
JP6322411B2 (en) 2011-09-30 2018-05-09 中外製薬株式会社 Antigen-binding molecules that promote the disappearance of antigens with multiple physiological activities
BR112014013081A2 (en) 2011-11-30 2020-10-20 Chugai Seiyaku Kabushiki Kaisha drug-containing cell vehicle for formation of an immune complex
LT3233921T (en) 2014-12-19 2021-12-10 Chugai Seiyaku Kabushiki Kaisha Anti-c5 antibodies and methods of use
JP6227191B1 (en) 2014-12-19 2017-11-08 中外製薬株式会社 Anti-myostatin antibody, polypeptide comprising mutant Fc region, and method of use
JP7141336B2 (en) 2015-12-25 2022-09-22 中外製薬株式会社 Anti-myostatin antibodies and methods of use
JP6527643B2 (en) 2016-08-05 2019-06-05 中外製薬株式会社 Composition for treating or preventing IL-8 related diseases
EP3574010A4 (en) 2017-01-30 2020-12-16 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use
CN110724204B (en) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Method for purifying Fc fusion protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
ATE14269T1 (en) * 1981-02-26 1985-08-15 Unilever Nv METHOD AND DEVICE FOR RECOVERING IMMUNOGLOBULINES.
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
EP0105359A1 (en) 1984-04-18
AU622099B2 (en) 1992-04-02
ES8706964A1 (en) 1987-07-01
CA1209907A (en) 1986-08-19
ES521371A0 (en) 1984-05-16
ES8506902A1 (en) 1985-08-01
GB2128630A (en) 1984-05-02
FI88403B (en) 1993-01-29
GB2128630B (en) 1986-08-28
ES8404858A1 (en) 1984-05-16
ES528000A0 (en) 1985-08-01
ATA901983A (en) 1991-03-15
CH672028A5 (en) 1989-10-13
FI834530A0 (en) 1983-12-09
EP0105359A4 (en) 1984-08-20
DK192191D0 (en) 1991-11-26
IT8320550A0 (en) 1983-04-12
FI88403C (en) 1993-05-10
DK192191A (en) 1991-11-26
AT393386B (en) 1991-10-10
FI834530A (en) 1983-12-09
ES528001A0 (en) 1987-07-01
AU7256987A (en) 1987-09-03
WO1983003678A1 (en) 1983-10-27
IT1219779B (en) 1990-05-24

Similar Documents

Publication Publication Date Title
GB8332644D0 (en) Affinity purification of antigens
IL69861A0 (en) Immunoassay of antigens
DE3377531D1 (en) Immunoassay of antigens
DE3379047D1 (en) Separation of chlorosilanes
DE3376122D1 (en) Particulate dialytic silica
DE3372476D1 (en) Preparation of p-nitrosodiphenylamine
DE3377414D1 (en) Preparation of modified zeolites
DE3376562D1 (en) Purification of bisphenol-a
GB2121038B (en) Preparation of 6a 10a-trans-hexahydrodibenzopyranones
GB8333097D0 (en) Purification of oil
DE3371871D1 (en) Purification of gases
GB2122595B (en) Phosphohemihydrate purification
GB2122613B (en) Purification of phenol
DE3371191D1 (en) Purification of chlorosilanes
DE3379046D1 (en) Separation of chlorosilanes
GB2129426B (en) Compounds of thiatriazines
GB8325010D0 (en) Self-elevation of vehicles
GB8317345D0 (en) Preparation of arylethylamines
DE3378581D1 (en) Separation of chlorosilanes
DE3360784D1 (en) Preparation of nitro-olefins
GB2120656B (en) Preparation of thio-bis-phenols
GB8304857D0 (en) Manufacture of nitrophenetoles
GB2119794B (en) Purification of trehalose dimycolates
ZA832380B (en) Sanitere en/of onmatige voering
GB2121405B (en) Preparation of bischoline naphathalene-disulphonates

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930412